KNSA compared with TH: revenue, margins and what each company keeps, and the suppliers and customers both name

KNSAKiniksa Pharmaceuticals International, plc

Mkt capRevenueRevenue

THTarget Hospitality Corp.

Mkt capRevenueRevenue

Compare

KNSAKiniksa Pharmaceuticals International, plc

THTarget Hospitality Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KNSA2 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±13.9%▲+22.23%×1.60

Q2 FY26—▲+25.03%—

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.1%▼−2.67%×0.24

May 11 '26±9.1%▲+17.94%×1.97

= impliedKNSA realized, solidTH realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedspan: KNSA 91d · TH 277dSource: market data

Q1 FY26

±10.9%

▲+13.78%

×1.27

Q3 FY25±10.7%▼−15.54%×1.45

KNSAKiniksa Pharmaceuticals International, plc

92.17· pre 92.18· delayed

Mkt cap$7.2BRevenue$286MQ3 FY26Revenue$678MFY25

THTarget Hospitality Corp.

13.67· pre 13.67

Pre-marketSep 2 '83

Mkt cap$1.4BRevenue$85MQ2 FY26Revenue$321MFY25

Compare

Pre-marketSep 2 '83

KNSAKiniksa Pharmaceuticals International, plc

THTarget Hospitality Corp.

92.17pre 92.18delayed

Price

13.67pre 13.67

$7.2B

Mkt cap

$1.4B

Q3 FY26$286M

Revenue

$85MQ2 FY26

FY25$678M

Revenue

$321MFY25

KNSA92.17vsTH13.67Pre-marketSep 2 '83